Research Frontiers (REFR) Cash & Equivalents (2010 - 2026)

Research Frontiers has disclosed Cash & Equivalents across 17 years of filings, most recently posting $1.3 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.3 million, down 7.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 7.14% YoY), and the FY2025 annual result was $664299.0, down 66.69% from the prior year.
• Cash & Equivalents came in at $1.3 million for Q1 2026 at Research Frontiers, up from $664299.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.8 million in Q3 2022 to a low of $524985.0 in Q3 2023.
• The 5-year median for Cash & Equivalents is $1.9 million (2022), against an average of $2.0 million.
• Across the five-year window, Cash & Equivalents jumped 2224.19% in 2022 and slumped 89.06% in 2023, its largest moves.
• Research Frontiers' Cash & Equivalents stood at $4.2 million in 2022, then plunged by 41.48% to $2.5 million in 2023, then dropped by 19.46% to $2.0 million in 2024, then plunged by 66.69% to $664299.0 in 2025, then surged by 95.7% to $1.3 million in 2026.
• The last three Cash & Equivalents figures came in at $1.3 million (Q1 2026), $664299.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.